Patient-led surveillance after treatment of localized melanoma
Source: MDLinx, November 2021
Findings indicate the safety and feasibility of patient-led surveillance after treatment of localized melanoma. Also, this intervention was acceptable.
- This pilot randomized clinical trial included 100 patients who had received treatment for localized melanoma, had a smartphone, had a partner to assist with skin self-examination (SSE), and had been routinely attending scheduled follow-up visits.
- They were randomized to patient-led (n = 49) or clinician-led (n = 51) surveillance.
- Patient-led surveillance was linked with increased SSE frequency (odds ratio [OR], 3.5) and thoroughness (OR, 2.2), and had no detectable adverse impact on psychological outcomes, vs clinician-led surveillance.